TLR signaling by tumor and immune cells: a double-edged sword.
about
cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoformsTargeting C-Type Lectin Receptors for Cancer ImmunityPattern Recognition Receptors in Cancer Progression and MetastasisDrosophila at the intersection of infection, inflammation, and cancerMucins and toll-like receptors: kith and kin in infection and cancerToll-like Receptors in Ovarian Cancer as Targets for ImmunotherapiesThe biology of small leucine-rich proteoglycans in bone pathophysiologyDamage-Associated Molecular Patterns in the Course of Lung Cancer--A ReviewHarnessing the Microbiome to Enhance Cancer ImmunotherapySparstolonin B inhibits pro-angiogenic functions and blocks cell cycle progression in endothelial cellsCytokines regulate cysteine cathepsins during TLR responses.Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growthEffect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma.Blocking TLR2 activity attenuates pulmonary metastases of tumor.Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination.Toll-like receptor signaling in cell proliferation and survivalPoly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells.p52-Independent nuclear translocation of RelB promotes LPS-induced attachmentNo genetic relationship between TLR2 rs4696480, rs3804100, and rs3804099 gene polymorphisms and female breast cancer in Saudi populations.The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma.Toll-like receptor mediated regulation of breast cancer: a case of mixed blessings.High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.Circulating tumor cells promote the metastatic colonization of disseminated carcinoma cells by inducing systemic inflammationStudy of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasisCombinatorial treatment with polyI:C and anti-IL6 enhances apoptosis and suppresses metastasis of lung cancer cells.The same and not the same: heterogeneous functional activation of prostate tumor cells by TLR ligationToll-like receptor agonists in cancer therapy.Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia.Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells.Role of the innate immune response and tumor immunity associated with simian virus 40 large tumor antigen.Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunityTLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivoDistinct innate immune gene expression profiles in non-melanoma skin cancer of immunocompetent and immunosuppressed patientsGene silencing of Toll-like receptor 2 inhibits proliferation of human liver cancer cells and secretion of inflammatory cytokinesMicroRNA-574-5p was pivotal for TLR9 signaling enhanced tumor progression via down-regulating checkpoint suppressor 1 in human lung cancerTLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence.TLR3 correlated with cervical lymph node metastasis in patients with papillary thyroid cancer.TLR4 activates NF-κB in human ovarian granulosa tumor cells.Analyzing serum-stimulated prostate cancer cell lines after low-fat, high-fiber diet and exercise intervention.
P2860
Q24311676-5930040D-CBB0-48E6-8B8F-2E531EA4E841Q26784483-A3E217DA-59D7-4C7D-A323-2D10A96FB9F0Q26798034-F580326C-F3ED-43CD-BC8B-2BE51663F75FQ26827570-9C5D2B1B-7D59-4EA0-98F4-3E7C82F96A90Q26830597-E830EDCF-6572-4F7A-B658-3D12A859E595Q26861234-1D197401-AD91-4BF5-96A2-82D7BC931331Q26861290-7A4E55E9-3374-4B77-8BCB-9A648F375485Q28082222-2A08BBCA-9EBB-455F-AAEC-AE0AC8FF2761Q28088598-86867428-3471-488D-9ECE-5349EB0E0F8FQ28535129-0F1BAAB4-68A9-4764-9CD8-71FB4C975899Q30429045-A3F305EE-71A3-413D-A9FC-06917E2F463CQ30842176-38EA88AE-4A68-4152-A915-C5A5F8B9D6B9Q31170767-35A237A1-BFDE-4562-AE2C-FF95B51514B0Q33490618-69033C74-AB7F-4560-81CA-1972A8CA69CFQ33577585-FBBEB7D7-BFC7-4CCE-BCBF-6FADF1531BD3Q33598805-5D577DBE-EBA8-46E9-AF28-2F46C8A5EF41Q33615280-25DF0DBF-3026-4C97-B96B-189D286BF6C4Q33615344-F9966C60-E72F-49F6-9D19-D174C2735F9EQ33632400-E5A31B7F-88FF-42BA-968F-609CAB809B8CQ33648709-C21DFD50-3B16-4F7E-9F06-F43AB72C7248Q33658124-6C9DEE09-19A3-4B3E-90A0-4A61BD703193Q33708134-BA7E8CD2-4AB5-46DF-8B24-3A841EA23D5BQ33709719-20C67F6C-3940-4594-8AE6-D1B802190A76Q33762632-B3C93E7D-AA4C-46D3-8E0D-F2E14AC2367EQ33779298-0C694CB0-A04C-44B0-BB2F-C444D8DCAEEBQ33801246-2C9CE169-9CD5-46CC-A418-1BCDBE7F50B5Q33918509-6228BB53-1376-428B-96D9-41A4E4997E0FQ34022013-2D562F11-5115-49A9-9642-52EBF1CCC6E1Q34056568-935C34CF-BF0D-49B0-832D-799956A2C91EQ34110914-86FCEFE9-A382-469A-996A-E89AB384225CQ34120703-7AF75079-9F9F-4AF9-834A-B1F724EC290EQ34153811-DC3A031D-DF5B-4D92-A22E-23476EA67A5FQ34320769-AEFC91C4-E10F-4CE7-9AB6-ACA7611FD663Q34342371-A7A9B33C-86E1-43E3-AB42-9F6521691298Q34344636-9E8169B1-1B29-4C73-AE1A-AA1E8786FCEDQ34469678-14434C7E-1138-4E4C-9CED-5AEF075FE74DQ34880391-494C8C37-D4BF-492B-B484-E5EEFC3C8351Q35017077-96BD6A31-E2B4-49C2-AB0D-0E77DC09C26BQ35056554-15C20180-BA6F-4052-9FBE-DE4049B1ED0EQ35103739-F87BD242-0403-4588-8FCD-B4B2533E646A
P2860
TLR signaling by tumor and immune cells: a double-edged sword.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TLR signaling by tumor and immune cells: a double-edged sword.
@en
TLR signaling by tumor and immune cells: a double-edged sword.
@nl
type
label
TLR signaling by tumor and immune cells: a double-edged sword.
@en
TLR signaling by tumor and immune cells: a double-edged sword.
@nl
prefLabel
TLR signaling by tumor and immune cells: a double-edged sword.
@en
TLR signaling by tumor and immune cells: a double-edged sword.
@nl
P2093
P2860
P356
P1433
P1476
TLR signaling by tumor and immune cells: a double-edged sword.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1210904
P407
P577
2008-01-01T00:00:00Z